HER2-intronic miR-4728-5p facilitates HER2 expression and accelerates cell proliferation and migration by targeting EBP1 in breast cancer
Yu Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Chen Wang(Tongji University), Yimin Quan(Chinese Academy of Medical Sciences & Peking Union Medical College), Xi Chen(Baylor College of Medicine), Yuan Yuan(First Hospital of China Medical University), Chunyu Liu(Jiamusi University), Minghui Liu(The University of Texas MD Anderson Cancer Center), Zhen Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Xueliang Wang(Sun Yat-sen University), Xiangfeng Meng(Jining Normal University), Liuyi Li(Zhejiang Chinese Medical University), Mengchao Yu(Qingdao University), Chen‐Yu Zhang(Central South University), Xiuting Hu(State Key Laboratory of Food Science and Technology)
Cited by 18
Related Papers
Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells
|Cancer Cell|2013|320
<i>TBX6</i> Null Variants and a Common Hypomorphic Allele in Congenital Scoliosis
|New England Journal of Medicine|2015|317
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
|Cancer Informatics|2012|303
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
|Journal of Clinical Investigation|2018|260
Iron-dependent histone 3 lysine 9 demethylation controls B cell proliferation and humoral immune responses
|Nature Communications|2019|224